Luteinizing hormone supplementation increases pregnancy rates in gonadotropin-releasing hormone antagonist donor cycles
- 31 August 2004
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 82 (2) , 343-347
- https://doi.org/10.1016/j.fertnstert.2004.03.020
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cyclesFertility and Sterility, 2003
- Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocolArchiv für Gynäkologie, 2001
- Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulationHuman Reproduction, 2001
- Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulationFertility and Sterility, 2001
- Embryo implantation and GnRH antagonistsHuman Reproduction, 2000
- Embryo implantation and GnRH antagonistsHuman Reproduction, 2000
- Postnatal Sex Reversal of the Ovaries in Mice Lacking Estrogen Receptors α and βScience, 1999
- Duration of Estrogen Exposure Prior to Follicle-Stimulating Hormone Stimulation is Critical to Granulosa Cell Growth and Differentiation in Rats1Biology of Reproduction, 1996
- Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyteThe Lancet, 1992
- Activated alpha subunit of Go protein induces oocyte maturation.Proceedings of the National Academy of Sciences, 1991